Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone for latency period in preterm premature rupture of membranes
IRCT2014020216453N1Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of progesterone in Preterm prelabor rupture of membranes (PPROM), sponsored by Kerman University of Medical Sciences. Primary endpoint: Latency period duration. Started Mar 2012; status: completed.
02
Drugs
progesterone
03
Conditions
Preterm prelabor rupture of membranes (PPROM)
Beyond the preview
Go deeper on IRCT2014020216453N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014020216453N1.